16:20 ~ 16:40 |
Androgen receptor directed therapy in the contemporary era |
Daniel DANILA (USA) |
|
16:40 ~ 16:50 |
Treatment options for mHSPC, advances and barriers |
Taek Sang KIM (Korea) |
|
16:50 ~ 17:00 |
What is the optimal target for radiotherapy? Primary only, primary plus nodes, primary plus nodes plus metastases? |
Byung Hoon KIM (Korea) |
|
17:00 ~ 17:10 |
Can genomic information assist in treatment decisions in the management of mHSPC? |
Hyun Chul CHUNG (Korea) |
|
17:10 ~ 17:40 |
Case-Based Panel Discussion : Presentation Case 1, 2 |
Soodong KIM (Korea) Sung Dae KIM (Korea) Jongwook PARK (Korea) Hyung Joon KIM (Korea) |
|